TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) — REVIVE THERAPEUTICS LTD. (CSE: RVV; OTCQB: RVVTF) (“ Revive” or the “Company”) is pleased to announce that it is arranging a private placement of a minimum of $3 million and up to $5 million of units (each, a “Unit”), at a price of $0.15 per Unit; (the “Offering”). The Offering is being led by EMD Financial Inc. Each Unit shall be comprised of one common…

Source

Previous articleClearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial
Next articleFILAMENT HEALTH ANNOUNCES NEW UNITED STATES PATENT ISSUANCES